IP Library › Granted Patent US 10,967,560
Granted Patent B2
US 10,967,560 · App. 15/816,640 · Granted Apr 6, 2021

Devices, systems, and methods for the fabrication of tissue

Inventors: Keith Murphy (Palos Verdes Estates, CA); Scott Dorfman (Baltimore, MD); Nathan Smith (Ferntree Gully, AU); Larry Bauwens (Lilydale, AU); Ian Sohn (Glen Iris, AU); Tim McDonald (Mount Waverly, AU); Chris Leigh-Lancaster (Murrumbeena, AU); Richard Jin Law (Stamford, CT)
Assignee: Organovo, Inc.
B29C64/106B01L3/0268B28B1/001B29C64/20B33Y30/00B41J3/407C12M21/08C12M33/00B33Y50/02B33Y70/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,967,560
App. No.
15/816,640
Granted
Apr 6, 2021
Kind
B2
Abstract

Described herein are bioprinters comprising: one or more printer heads, wherein a printer head comprises a means for receiving and holding at least one cartridge, and wherein said cartridge comprises contents selected from one or more of: bio-ink and support material; a means for calibrating the position of at least one cartridge; and a means for dispensing the contents of at least one cartridge. Further described herein are methods for fabricating a tissue construct, comprising: a computer module receiving input of a visual representation of a desired tissue construct; a computer module generating a series of commands, wherein the commands are based on the visual representation and are readable by a bioprinter; a computer module providing the series of commands to a bioprinter; and the bioprinter depositing bio-ink and support material according to the commands to form a construct with a defined geometry.

Claims (24)

1. A bio-ink cartridge for use with an automated bio-printer, the bio-ink cartridge comprising:

a bio-ink comprising a plurality of human cells and a cell culture media, the plurality of human cells comprise multicellular aggregates, at least a first multicellular aggregate is cohered to at least a second multicellular aggregate, the bio-ink is a cell suspension;

a deposition orifice, wherein the bio-ink is primed with respect to the deposition orifice; and

wherein the bio-ink cartridge is attachable to an automated bio-printer and the bio-ink cartridge is controllable by the automated bio-printer, wherein the bio-ink is primed with respect to the deposition orifice using a laser beam.

2. The bio-ink cartridge of claim 1 , wherein the bio-ink is a homologous ink.

3. The bio-ink cartridge of claim 1 , wherein the bio-ink is a heterologous ink.

4. The bio-ink cartridge of claim 1 , wherein the plurality of human cells further comprise differentiated cells.

5. The bio-ink cartridge of claim 1 , wherein the plurality of human cells further comprise non-differentiated cells.

6. The bio-ink cartridge of claim 1 , wherein the plurality of human cells further comprise a mixture of differentiated cells and non-differentiated cells.

7. The bio-ink cartridge of claim 5 , wherein the non-differentiated cells comprise stem cells.

8. The bio-ink cartridge of claim 7 , wherein the stem cells comprise progenitor cells.

9. The bio-ink cartridge of claim 7 , wherein the stem cells comprise pluripotent cells.

10. The bio-ink cartridge of claim 1 , wherein the cell culture media comprises lipids.

11. The bio-ink cartridge of claim 1 , wherein the cell culture media comprises cytokines.

12. The bio-ink cartridge of claim 1 , wherein the cell culture media comprises sugars.

13. The bio-ink cartridge of claim 1 , wherein the cell culture media comprises vitamins.

14. The bio-ink cartridge of claim 1 , wherein the cell culture media comprises amino acids.

15. The bio-ink cartridge of claim 1 , wherein the bio-ink further comprises an extrusion compound, the extrusion compound is a hydrogel, the bio-ink is extrudable, and the bio-ink is shaped by the deposition orifice when the bio-ink is extruded through the deposition orifice.

16. The bio-ink cartridge of claim 1 , wherein the plurality of human cells comprise liver cells.

17. The bio-ink cartridge of claim 1 , wherein the plurality of human cells comprise kidney cells.

18. The bio-ink cartridge of claim 1 , wherein the bio-ink is a semi-solid composition.

19. The bio-ink cartridge of claim 1 , wherein the bio-ink has a viscosity of about 1,000 centipoise to about 400,000 centipoise.

20. The bio-ink cartridge of claim 1 , wherein the deposition orifice further comprises an inner diameter of about 1 μm to about 1000 μm.

21. The bio-ink cartridge of claim 1 , wherein the bio-ink is primed by compacting and advancing the bio-ink until it is located in a position in contact with the dispensing orifice.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2020
From: MURPHY, KEITH; DORFMAN, SCOTT; SMITH, NATHAN; BAUWENS, LARRY; SOHN, IAN; MCDONALD, TIM; LEIGH-LANCASTER, CHRIS; LAW, RICHARD JIN
To: ORGANOVO, INC.
Reel/Frame 054516/0435 →
Continuity (6)
Continuation 14950567 · Nov 24, 2015
Continuation 14530499 · Oct 31, 2014
Continuation 13968313 · Aug 15, 2013
Continuation 13246428 · Sep 27, 2011
Provisional Application 61405582 · Oct 21, 2010
Related Publication 20180093015A1 · Apr 5, 2018
Cited By (4)
US 12,252,712 US 12,365,877 US 12,545,897 US 12,576,188